STOCK TITAN

Orchestra BioMed CEO has 6,566 shares withheld

OBIO’s CEO reported share withholding for RSU tax obligations, with no market sales and substantial direct and trust holdings remaining.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) reported that Chief Executive Officer and Chairperson David P. Hochman had 6,566 shares of Common Stock withheld on September 10, 2026 to satisfy tax withholding obligations upon vesting of restricted stock units. According to the disclosure, no shares were sold in the market in connection with this event.

After these tax-withholding transactions, Hochman held 1,067,463 shares directly and 432,916 shares indirectly through the DPH 2008 Trust, as well as additional indirect holdings through several family trusts. No Rule 10b5-1 trading plan is reported for these transactions.

Positive

  • None.

Negative

  • None.
Insider Hochman David P
Role See Remarks
Type Security Shares Price Value
Tax Withholding Common Stock, par value $0.0001 per share ("Common Stock") F1 3,283 $5.81 $19K
Tax Withholding Common Stock F1 3,283 $5.81 $19K
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock, par value $0.0001 per share ("Common Stock") — 1,067,463 shares (Direct); Common Stock — 432,916 shares (Indirect, By the DPH 2008 Trust); Common Stock — 2,000 shares (Indirect, By the Solomon Ascher Hochman 2019 Trust); Common Stock — 2,000 shares (Indirect, By the Hannah Hochman 2019 Trust); Common Stock — 2,000 shares (Indirect, By the Judah Herman Hochman 2019 Trust); Common Stock — 3,140 shares (Indirect, By the NSH 2008 Family Trust)
Footnotes (1)
  1. F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
Shares withheld for tax obligations 6,566 shares Total Common Stock withheld on September 10, 2026 for RSU-related tax withholding
Direct shares withheld 3,283 shares Common Stock withheld from David P. Hochman’s direct holdings on September 10, 2026
Indirect shares withheld (DPH 2008 Trust) 3,283 shares Common Stock withheld from shares held by the DPH 2008 Trust on September 10, 2026
Reference price per share $5.81 per share Price reported for the tax-withholding dispositions on September 10, 2026
Direct holdings after transaction 1,067,463 shares Common Stock directly owned by David P. Hochman after the tax-withholding disposition
DPH 2008 Trust holdings after transaction 432,916 shares Common Stock indirectly owned via the DPH 2008 Trust after the tax-withholding disposition
Holdings per 2019 family trust 2,000 shares Common Stock indirectly held by each of the Solomon Ascher, Hannah, and Judah Herman Hochman 2019 Trusts
NSH 2008 Family Trust holdings 3,140 shares Common Stock indirectly held by the NSH 2008 Family Trust
restricted stock units ("RSUs") financial
"in connection with vesting of restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
tax withholding obligations financial
"to satisfy tax withholding obligations in connection with vesting of RSUs."
indirect ownership financial
"Common Stock indirectly owned "By the DPH 2008 Trust" and other trusts."
withholding of shares financial
"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OBIO’s CEO David P. Hochman report in this Form 4?

He reported that 6,566 shares of OBIO Common Stock were withheld on September 10, 2026 to cover tax withholding obligations related to vesting of RSUs. The filing states that no shares were sold in the market due to this vesting and tax withholding.

How many OBIO shares were withheld for taxes in the September 10, 2026 transactions?

A total of 6,566 shares of Orchestra BioMed Common Stock were withheld for tax obligations, consisting of 3,283 shares from David P. Hochman’s direct holdings and 3,283 shares from shares held indirectly through the DPH 2008 Trust, at a reference price of $5.81 per share.

Were any OBIO shares sold in the market as part of these Form 4 transactions?

No. The footnote explains that the transactions represent withholding of shares by Orchestra BioMed to satisfy RSU-related tax obligations, and explicitly states that no shares were sold in the market as a result of the RSU vesting and tax withholding.

What are David P. Hochman’s OBIO direct holdings after these transactions?

Following the September 10, 2026 tax-withholding events, David P. Hochman held 1,067,463 shares of Orchestra BioMed Common Stock directly. This figure is reported as the total number of shares owned directly after the disposition for tax withholding.

What OBIO shares does the DPH 2008 Trust hold after the reported transactions?

After the September 10, 2026 withholding, the DPH 2008 Trust held 432,916 shares of Orchestra BioMed Common Stock indirectly attributable to David P. Hochman. The filing identifies this position as indirect ownership “By the DPH 2008 Trust.”

Were the OBIO Form 4 transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 plan is reported for these transactions. The share movements relate to tax withholding on RSU vesting rather than open-market purchases or sales under a trading plan.

What additional OBIO shares are held through other family trusts?

The report lists indirect holdings of 2,000 shares each by the Solomon Ascher Hochman 2019 Trust, the Hannah Hochman 2019 Trust, and the Judah Herman Hochman 2019 Trust, plus 3,140 shares held by the NSH 2008 Family Trust, all in Orchestra BioMed Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hochman David P

(Last)(First)(Middle)
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE

(Street)
NEW HOPE PENNSYLVANIA 18938

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.0001 per share ("Common Stock")09/10/2026F(1)3,283D$5.811,067,463D
Common Stock09/10/2026F(1)3,283D$5.81432,916IBy the DPH 2008 Trust
Common Stock2,000IBy the Solomon Ascher Hochman 2019 Trust
Common Stock2,000IBy the Hannah Hochman 2019 Trust
Common Stock2,000IBy the Judah Herman Hochman 2019 Trust
Common Stock3,140IBy the NSH 2008 Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
Remarks:
Chief Executive Officer and Chairperson
/s/ Andrew Taylor, Attorney-in-Fact09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading